Dr. Mehdi Djekidel, MD

Dr. Djekidel practices at TGH Imaging - Bloomingdale in Brandon, Florida.

Dr. Djekidel's NPI, 1386857357, was assigned on May 7, 2007. Dr. Djekidel graduated from University D'Alger, Inst Natl D'Ensign Sup En Sci Med in 2002. Dr. Djekidel's Connecticut license number on file is 47906.

Dr. Djekidel's primary practice is TGH Imaging - Bloomingdale, at 3350 Bell Shoals Rd, Brandon, FL 33511. The practice phone is (813) 654-4883.

Dr. Djekidel's primary practice is TGH Imaging - Bloomingdale in Brandon, Florida. Dr. Djekidel is also affiliated with North Shore University Hospital. The medical group on file is MBB Radiology. Dmand AI also links Dr. Djekidel to 4 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Djekidel practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Djekidel's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Djekidel is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Djekidel's licenses on file in 3 states: Connecticut, Michigan and New York.

CMS data shows 948 Medicare services from Dr. Djekidel across 21 procedure codes in 2024, for 809 Medicare patients. Medicare paid $53,750 for them.

CMS counts 809 Medicare patients who saw Dr. Djekidel in 2024. The largest group is 75 to 84, with 309 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Djekidel's median patient age at 67, with 59% women.

In 2024, Dr. Djekidel wrote 56 Medicare Part D claims for 36 patients. 98% of them were for generic drugs. CMS names the drug for 51 of them, across 2 drugs with 11 or more claims each, at $262 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Djekidel for performance year 2024, reported through an alternative payment model (APM). Dr. Djekidel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. Djekidel, published from 2014 to 2023. 2023 was the busiest year, with 3. The most frequent topics are Positron-Emission Tomography, Adenocarcinoma and Fluorodeoxyglucose F18. Dr. Djekidel has published most often in J Nucl Med Technol. Dr. Djekidel's most frequent co-authors are Michael Paul Kane, MD and Mark Heinz Michalski, MD.

CMS Open Payments shows 5 general payments to Dr. Djekidel from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GE Healthcare paid the most, $226.

Dr. Djekidel graduated from University D'Alger, Inst Natl D'Ensign Sup En Sci Med in 2002.

Dr. Djekidel is in network with 18 carriers, including MVP Health Care, United Healthcare and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.